- Report
- June 2025
- 150 Pages
Global
From €2443EUR$2,699USD£2,093GBP
- Report
- June 2025
- 150 Pages
Global
From €2443EUR$2,699USD£2,093GBP
- Report
- June 2025
- 400 Pages
Global
From €4480EUR$4,949USD£3,838GBP
- Report
- April 2023
- 160 Pages
Global
From €4480EUR$4,949USD£3,838GBP
- Report
- May 2024
- 136 Pages
Global
From €3620EUR$3,999USD£3,101GBP
- Report
- August 2022
- 114 Pages
Global
From €4300EUR$4,750USD£3,684GBP
- Report
- May 2024
- 129 Pages
Global
From €3620EUR$3,999USD£3,101GBP
- Report
- March 2025
- 81 Pages
Global
From €16289EUR$17,995USD£13,955GBP
- Report
- May 2024
- 72 Pages
Global
From €3164EUR$3,495USD£2,710GBP
- Report
- May 2024
- 250 Pages
Global
From €4522EUR$4,995USD£3,874GBP
- Report
- March 2024
- 185 Pages
Asia Pacific
€4522EUR$4,995USD£3,874GBP
- Report
- March 2026
- 213 Pages
Canada
From €4390EUR$4,850USD£3,761GBP
- Report
- March 2026
- 218 Pages
China
From €4390EUR$4,850USD£3,761GBP
- Report
- March 2026
- 223 Pages
India
From €4390EUR$4,850USD£3,761GBP
- Report
- March 2026
- 228 Pages
Germany
From €4390EUR$4,850USD£3,761GBP
- Report
- March 2025
- 150 Pages
Global
From €4390EUR$4,850USD£3,761GBP
- Report
- March 2024
- 127 Pages
Europe
From €1358EUR$1,500USD£1,163GBP
- Report
- March 2024
- 240 Pages
Global
From €3259EUR$3,600USD£2,792GBP
- Report
- March 2024
- 128 Pages
Asia Pacific
From €1358EUR$1,500USD£1,163GBP
- Report
- March 2024
- 119 Pages
North America
From €1358EUR$1,500USD£1,163GBP

The Alopecia Drug market is a subset of the Immune Disorders Drugs market, which focuses on treatments for autoimmune diseases. Alopecia is an autoimmune disorder that causes hair loss, and drugs used to treat it are designed to reduce inflammation and suppress the immune system. These drugs are typically administered orally or topically, and may include corticosteroids, immunosuppressants, and biologics.
The Alopecia Drug market is highly competitive, with many companies developing treatments for the disorder. Some of the major players in the market include Pfizer, Novartis, Merck, Johnson & Johnson, and GlaxoSmithKline. Other companies, such as Sun Pharmaceuticals, Cipla, and Dr. Reddy's Laboratories, are also active in the market. Show Less Read more